Export 9 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Author is Trojanowski, John Q  [Clear All Filters]
Journal Article
T. C. Durazzo, Korecka, M., Trojanowski, J. Q., Weiner, M. W., Hara, R. O. ', Ashford, J. W., and Shaw, L. M., Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers., J Alzheimers Dis, vol. 54, no. 1, pp. 99-107, 2016.
J. B. Toledo, Habes, M., Sotiras, A., Bjerke, M., Fan, Y., Weiner, M. W., Shaw, L. M., Davatzikos, C., and Trojanowski, J. Q., APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points., J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
K. Talbot, Wang, H. - Y., Kazi, H., Han, L. - Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., Arvanitakis, Z., Schneider, J. A., Wolf, B. A., Bennett, D. A., Trojanowski, J. Q., and Arnold, S. E., Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline., J Clin Invest, vol. 122, no. 4, pp. 1316-38, 2012.
O. M. Al-Janabi, Brown, C. A., Bahrani, A. A., Abner, E. L., Barber, J. M., Gold, B. T., Goldstein, L. B., Murphy, R. R., Nelson, P. T., Johnson, N. F., Shaw, L. M., Smith, C. D., Trojanowski, J. Q., Wilcock, D. M., and Jicha, G. A., Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension., J Alzheimers Dis, vol. 66, no. 3, pp. 1095-1104, 2018.
C. R. Jack, Vemuri, P., Wiste, H. J., Weigand, S. D., Aisen, P. S., Trojanowski, J. Q., Shaw, L. M., Bernstein, M. A., Petersen, R. C., Weiner, M. W., and Knopman, D. S., Evidence for ordering of Alzheimer disease biomarkers., Arch Neurol, vol. 68, no. 12, pp. 1526-35, 2011.
H. Wang, Stewart, T., Toledo, J. B., Ginghina, C., Tang, L., Atik, A., Aro, P., Shaw, L. M., Trojanowski, J. Q., Galasko, D. R., Edland, S., Jensen, P. H., Shi, M., and Zhang, J., A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 4, pp. 1541-1553, 2018.
B. T. Hyman, Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., Nelson, P. T., Schneider, J. A., Thal, D. Rudolf, Thies, B., Trojanowski, J. Q., Vinters, H. V., and Montine, T. J., National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease., Alzheimers Dement, vol. 8, no. 1, pp. 1-13, 2012.
K. D. Deters, Risacher, S. L., Kim, S., Nho, K., West, J. D., Blennow, K., Zetterberg, H., Shaw, L. M., Trojanowski, J. Q., Weiner, M. W., and Saykin, A. J., Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease., J Alzheimers Dis, vol. 58, no. 4, pp. 1245-1254, 2017.
C. R. Jack, Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., Lesnick, T. G., Pankratz, V. S., Donohue, M. C., and Trojanowski, J. Q., Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers., Lancet Neurol, vol. 12, no. 2, pp. 207-16, 2013.